E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers V > Headlines for VaxGen, Inc. > News item
Published on 10/30/2008 in the Prospect News Convertibles Daily and Prospect News PIPE Daily.

VaxGen buys back $5 million more of its 5.5% convertibles

By Devika Patel

Knoxville, Tenn., Oct. 30 - VaxGen, Inc. repurchased $5 million of its 5.5% convertible senior subordinated notes due April 2010 from Drawbridge Special Opportunities Fund LP, according to an 8-K filed Thursday with the Securities and Exchange Commission.

VaxGen will pay $4.15 million for notes, plus accrued interest of $20,625.03 based on an assumed settlement date of Oct. 28.

VaxGen is a Brisbane, Calif., biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.